December 12, 2024 1 min read Okogen announced completion of $3.3 million in financing to advance the company through its phase 2b clinical program for acute infectious conjunctivitis, as well as support development of an AI-driven image evaluation platform. “This milestone reinforces our commitment to delivering comprehensive therapeutic solutions for patients suffering … [Read more...] about Okogen completes funding for phase 2b clinical program for acute infectious conjunctivitis
News
FDA clears investigational new drug application for Stargardt disease gene therapy
December 12, 2024 1 min read Key takeaways: SB-007 is designed to treat address the root genetic cause of Stargardt disease. A phase 1/2 study investigating the safety and efficacy of the therapy is set to begin in 2025. The FDA cleared an investigational new drug application for SB-007, an adeno-associated viral vector gene therapy … [Read more...] about FDA clears investigational new drug application for Stargardt disease gene therapy
Tenpoint Therapeutics and Visus Therapeutics complete merger, combining ophthalmic therapeutics portfolios
Tenpoint Therapeutics Ltd. and Visus Therapeutics Inc. have completed their merger, consolidating their respective ophthalmic therapeutic assets. The new entity aims to address ocular conditions related to aging, with a focus on presbyopia, cataracts, and geographic atrophy.A central component of the merged portfolio is BRIMOCHOL PF, a once-daily, presbyopia-correcting eye … [Read more...] about Tenpoint Therapeutics and Visus Therapeutics complete merger, combining ophthalmic therapeutics portfolios
4-Year research validates DOT 0.2 spectacle lenses as early myopia treatment
The results of a recent study showed that Diffusion Optics Technology (DOT) 0.2 spectacle lenses (SightGlass Vision) are safe and effective for reducing myopia progression in young children. The lenses showed an additional benefit in the 4th year of wear. The study results supported the hypothesis that a mild reduction in retinal contrast can slow myopia progression in young … [Read more...] about 4-Year research validates DOT 0.2 spectacle lenses as early myopia treatment
Part 8: Advice from the experts: Helpful information for current residents
In this series, experts in the field advise current residents and offer insight into how they can make the most of their time and experience moving forward with their careers.Video Transcript:Editor's note: The below transcript has been lightly edited for clarity.Veidehi Dedania, MD:One of the most important things to remember is, what are your goals in your career? And … [Read more...] about Part 8: Advice from the experts: Helpful information for current residents
VIDEO: Switching to latanoprostene bunod beneficial for lowering IOP
December 12, 2024 4 min watch CHICAGO — In this Healio Video Perspective from the AAO meeting, Constance O. Okeke, MD, MSCE, discusses a study that investigated the impact of latanoprostene bunod on IOP in patients with open-angle glaucoma and ocular hypertension. “We’re really excited about this data because what it could mean is further support that switching from a … [Read more...] about VIDEO: Switching to latanoprostene bunod beneficial for lowering IOP
VisiRose introduces investigational non-invasive therapy for infectious keratitis
VisiRose, a newly launched company formed in collaboration with Provectus Biopharmaceuticals and the University of Miami Miller School of Medicine’s Bascom Palmer Eye Institute (BPEI), is advancing the development of Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT). This investigational, non-invasive treatment targets infectious keratitis and other serious ocular … [Read more...] about VisiRose introduces investigational non-invasive therapy for infectious keratitis
Enhancing precision in GA imaging
Keeping a sharp eye on geographic atrophy (GA) associated with age-related macular degeneration is the goal and reaching it has gotten easier over the years with the introduction of more advanced technologies.SriniVas R. Sadda, MD, FARVO, a professor of ophthalmology at Doheny Eye Institute, University of California Los Angeles, described the advantages and disadvantages of the … [Read more...] about Enhancing precision in GA imaging
In-Office Suprachoroidal Viscopexy for Acute Rhegmatogenous Retinal Detachment
This case series study of 6 patients treated at a single center in Canada reports outcomes with in-office suprachoroidal viscopexy for primary acute rhegmatogenous retinal detachment. … [Read more...] about In-Office Suprachoroidal Viscopexy for Acute Rhegmatogenous Retinal Detachment
Fovea-Involved Outer Retinal Abnormality Induced by a Novel RET Inhibitor
This case report describes an outer retinal abnormality associated with taking a RET inhibitor during a clinical trial in a 52-year-old patient with right lung adenocarcinoma and a RET gene fusion. … [Read more...] about Fovea-Involved Outer Retinal Abnormality Induced by a Novel RET Inhibitor